AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
AdvaMed 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
My Profile
Member Center
Policy
Top Priorities
On behalf of our members, AdvaMed® works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
Your Featured Resources
Scott Whitaker Op-Ed: Medicare must keep pace with FDA-authorized breakthrough medical technologies
Medicare breakthrough medical technologies face delays between FDA authorization and coverage decisions, slowing patient access to innovation.
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical…
AdvaMed® 2026 State Policy Briefing Series
Explore the 2026 State Policy Briefing Series for insights on medtech policy, legislative activity, and regulatory updates impacting the medtech industry.
AdvaMed® Comment Letter to OIG’s Annual Solicitation for Safe Harbors and Special Fraud Alerts
AdvaMed® comment letter to the OIG’s recommends updates to safe harbors, value-based arrangements, & oversight to support value-driven healthcare.
AdvaMed Plays Tariff Chess, Trump Plays Checkers
As tariff uncertainty continues in 2025, AdvaMed plays tariff chess, advocating for predictable, zero-for-zero policies to protect medtech innovation and access.
Additional Resources
AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
AdvaMed 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
Scott Whitaker Op-Ed: Medicare must keep pace with FDA-authorized breakthrough medical technologies
Medicare breakthrough medical technologies face delays between FDA authorization and coverage decisions, slowing patient access to innovation.
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical…
AdvaMed® 2026 State Policy Briefing Series
Explore the 2026 State Policy Briefing Series for insights on medtech policy, legislative activity, and regulatory updates impacting the medtech industry.
Discover More Resources
AdvaMed® members have access to our full library of industry resources.
You are not logged in to the AdvaMed Hub.
AdvaMed® Awards: Celebrating Medtech Career Excellence
AdvaMed highlights its annual Awards program recognizing leaders whose careers have advanced innovation, patient access, and excellence across the medtech ecosystem.
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
HALIFAX, NS, Feb. 24, 2026 /PRNewswire/ – ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, today announced the completion…
ATRO Medical Secures €3 Million to Advance Artificial Meniscus Toward Pivotal Studies
ATRO Medical, the Dutch clinical-stage orthopedic company developing a novel artificial meniscus implant for patients suffering from post-meniscectomy pain, today announces the successful closing of a €3 million financing round.…
i-GENTIC AI Launches Context-Aware MedTech Agents to Strengthen FDA 510(k) Submission Consistency
PALO ALTO, Calif., Feb. 11, 2026 i-GENTIC AI today announced a new suite of context-aware, multilingual MedTech agents designed to help medical device manufacturers improve the quality and consistency of…
ICYMI: AdvaMed’s Scott Whitaker on Supreme Court Tariffs Decision, Next Steps
Scott Whitaker, president and CEO of AdvaMed, the world’s largest trade association representing medtech innovators, released the following statement after Fridays’ Supreme Court ruling on tariffs. Today, he published a more fulsome readout on LinkedIn, available here.
Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector
WASHINGTON—AdvaMed, the Medtech Association, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of the AdvaMed Diabetes Sector, succeeding Chris…
Why Practical FDA Submissions Training Makes the Difference
Explore AdvaMed’s Medical Device Submissions Workshop Series from practical submission strategies to live expert insights you can apply immediately.
The Pulse of Medtech Payment: Join Us at the 2026 Payment Policy Forum
The 2026 AdvaMed Payment Policy Forum takes place May 28–29 in Washington, D.C. at Hogan Lovells Office. Registration is now open, and as always, AdvaMed members receive preferred pricing.
AdvaMed Urges Georgia Court of Appeals to Enforce Sound Science in Ethylene Oxide Litigation
WASHINGTON—AdvaMed, the Medtech Association, the world’s largest medtech trade association, representing over 650 medical technology innovators, has filed an amicus curiae brief in the Walker v. Becton, Dickinson and Company…
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in…
Membership Newsletter
We are pleased to provide AdvaMed® members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.